UPS, Cencora to expand their US operations; Evotec divests biosimilar business to Sandoznews2025-11-06T14:36:04+00:00November 6th, 2025|Endpoints News|
J&J’s Caplyta approved by FDA as add-on treatment for depressionnews2025-11-06T14:20:11+00:00November 6th, 2025|Endpoints News|
How UpToDate plans to compete in the race for doctors’ AI search toolsnews2025-11-06T14:00:00+00:00November 6th, 2025|Endpoints News|
Oura’s healthcare ambitions take shapenews2025-11-06T13:59:15+00:00November 6th, 2025|Endpoints News|
Low vaccine uptake hampers Moderna earnings, including meager RSV salesnews2025-11-06T12:00:52+00:00November 6th, 2025|Endpoints News|
AstraZeneca reports record-breaking quarter, says it can ‘absorb impact’ of US pricing dealnews2025-11-06T11:54:41+00:00November 6th, 2025|Endpoints News|
Lilly’s amylin moves to Phase 3 after success in next obesity drug wavenews2025-11-06T11:45:50+00:00November 6th, 2025|Endpoints News|
China lifts ban on Illumina’s DNA sequencersnews2025-11-06T03:19:41+00:00November 6th, 2025|Endpoints News|
Delaware judge refuses to block Metsera from ending Pfizer obesity dealnews2025-11-05T21:27:42+00:00November 5th, 2025|Endpoints News|
First Circuit hears arguments over NIH indirect cost cutsnews2025-11-05T20:29:34+00:00November 5th, 2025|Endpoints News|
